Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells

British Journal of Haematology

Volumn 93, Issue 3, 1996, Pages 551-557

  Carlo Stella, Carmelo ^a   Regazzi, Ester ^a   Garau, Daniela ^a   Mangoni, Lina ^a   Rizzo, Maria Teresa ^a   Bonati, Antonio ^b   Dotti, Gianpietro ^a   Almici, Camillo ^a   Rizzoli, Vittorio ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b METHODIST HOSPITAL   (United States)

Author keywords

Genistein; LTC IC; Marrow purging; Progenitor cells; Protein tyrosine kinases

Indexed keywords

GENISTEIN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR;

ARTICLE; BONE MARROW PURGING; CONTROLLED STUDY; GROWTH INHIBITION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL;

EID: 0029949993     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1694.x     Document Type: Article

References (34)

1. Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M. & Fukami, Y. (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinase. Journal of Biological Chemistry, 262, 5592-5595.
2. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton D.A.G., Gralnick, H.R. & Sultan, C. (1985) Proposed revised criteria for the classification of acute myeloid leukaemia: a report of the French-American-British Cooperative Group. Annals of Internal Medicine, 103, 620-625.
3. Bergamashi, G., Rosti, V., Danova, M., Ponchio, L., Lucotti, C. & Cazzola, M. (1995) Inhibitors of tyrosine phosphorylation induce apoptosis in human leukemic cell lines. Leukaemia, 7, 2012-2018.
4. Boyle, W.J. (1992) Growth factors and tyrosine kinase receptors during development and cancer. Current Opinion in Oncology, 4, 156-162.
5. Brenner, M.K., Rill, D.R., Moen, R.C., Krance, R.A., Mirro, J., Jr, Anderson, F.W. & Ihle, J.N. (1993) Gene-marking to trace origin of relapse alter autologous bone-marrow transplantation. Lancet, 341, 85-87.
6. Burke, T.R. (1994) Protein-tyrosine kinases: potential targets for anticancer drug development. Stem Cells, 12, 1-6.
7. + acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors. Leukemia, 4, 561-566.
8. Carlo-Stella, C., Mangoni, L., Piovani, G., Garau, D., Almici, C. & Rizzoli, V. (1994) Identification of Philadelphia-negative granulocyte-macrophage colony-forming units generated by stromaadherent cells from chronic myelogenous leukemia patients. Blood, 83, 1373-1380.
9. Coiffier, B., Philip, T., Burnett, A.K. & Symann, M.L. (1995) Consensus conference on intensive chemotherapy plus hematopoietic stem-cell transplantation in malignancies. Journal of Clinical Oncology, 12, 226-231.
10. Constantinou, A., Kiguchi, K. & Huberman, E. (1990) Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein. Cancer Research, 50, 2618-2624.
11. Cunningham, B.D., Threadgill, M.D., Groundwater, P.W., Dale, I.L. & Hickman, J.A. (1992) Synthesis and biological evaluation of a series of flavones designed as inhibitors of protein tyrosine kinases. Anti-Cancer Drug Design, 7, 365-384.
12. Gorin, N.C., Aegerter, P., Auvert, B., Meloni, G., Goldstone, A.H., Burnett, A., Carella, A., Korbling, M., Herve, P., Maraninchi, D., Löwenberg, B., Verdonck, L.F., de Planque, M., Hermans, J., Heibig, W., Porcellini, A., Rizzoli, V., Alessandrino, E.P., Franklin, I.M., Reiffers, J., Colleselli, P. & Goldman, J.M. (1990) Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging. Blood, 75, 1606-1614.
13. Hill, T.D., Dean, N.M., Mordan, L.J., Lau, A.F., Kanemitsu, M.Y. & Boynton, A.L. (1990) PDGF-induced activation of phospholipase C is not required for induction of DNA synthesis. Science, 248, 1660-1663.
14. Honna, Y., Okabe-Kado, J., Kasaukabe, T., Hozumi, M. & Umezawa, K. (1990) Inhibition of abl oncogene tyrosine kinase induces erythroid differentiation of human myelogenous leukemia K-562 cells. Japanese Journal of Cancer Research, 81, 1132-1136.
15. Hunter, T. (1995) Protein kinases and phosphatases: the Yin and Yang of protein phosphorylation and signaling. Cell, 80, 225-236.
16. Kishimoto, T., Taga, T. & Akira, S. (1994) Cytokine signal transduction. Cell, 76, 253-262.
17. Kuriu, A., Ikeda, H., Kanakura, Y., Griffin, J.D., Drucker, B., Yagura, H., Kitayama, H., Ishikawa, J., Nishiura, T. & Kanayama, Y. (1991) Proliferation of human myeloid leukemia cell line associated with the tyrosine phosphorylation and activation of the proto-oncogene c-kit product. Blood, 78, 2834-2840.
18. Levitzki, A. (1992) Tyrphostin: tyrosine kinase blockers as novel antiproliferative agents and dissectors of signal transduction. FASEB Journal, 6, 3275-3282.
19. Levitzki, A. & Gazit, A. (1995) Tyrosine kinase inhibition: an approach to drug development. Science, 267, 1782-1788.
20. Lowenstein, E.J., Daly, K.J., Batzer, A.G., Margolis, W.L., Lammers, R., Ullrich, A., Skolnik, E.Y., Bar-Sagi, D. & Schlessinger, J. (1992) The SH2 and SH3 domain-containing protein Grb2 links receptor tyrosine kinase to Ras signaling. Cell, 70, 431-442.
21. Okura, A., Arakawa, H., Oka, H., Yoshinari, T. & Monden, Y. (1988) Effect of genistein on topoisomerase activity and on the growth of (Val 12)Ha-ras-transformed NIH cells. Biochemical and Biophysical Research Communications, 157, 183-189.
22. Pawson, T. (1995) Protein modules and signalling networks. Nature, 373, 573-580.
23. Pawson, T. & Schlessinger, J. (1993) SH2 and SH3 domain. Journal of Current Biology, 3, 434-442.
24. Peterson, G. & Barnes, S. (1993) Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylalion. Prostate, 22, 335-345.
25. Rizzo, M.T., Boswell, S.H., Mangoni, L., Carlo-Stella, C. & Rizzoli, V. (1995) Arachidonic acid induces c-jun gene expression in stromal cells stimulated by interleukin-1 and tumor necrosis factor: evidence for a protein tyrosine kinase dependent process. Blood, 86, 2967-2975.
26. Rizzoli, V. & Carlo-Stella, C. (1995) Stem cell purging: an intriguing dilemma. Experimental Hematology, 23, 296-302.
27. Shannon, K. (1995) The Ras signaling pathway and the molecular basis of myeloid leukemogenesis. Current Opinion in Hematology, 2, 305-308.
28. Shpall, E.J., Jones, R.B., Bast, R.C., Rosner, G., Vandermark, M. Ross, M., Affronti, M.L., Johnston, C., Eggleston, S., Tepperberg, M., Coniglio, D. & Peters, W.P. (1990) 4-Hydroperoxycydophosphamide (4-HC) purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial. Journal of Clinical Oncology, 9, 85-93.
29. Sutherland, H.J., Eaves, C.J., Eaves, A.C., Dragowska, A.C. & Lansdorp, P.M. (1990) Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood, 74, 1563-1570.
30. Sutherland, H.J., Eaves, C.J., Lansdorp, P.M., Tacker, J.D. & Hogge, D.E. (1993) Differential regulation of primitive human hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells. Blood, 78, 666-672.
31. Tohda, S., Nara, N., Imai, Y. & Aoki, N. (1991) Effect of protein kinase inhibitors on the proliferation of leukemic cells stimulated by granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor or interleukin-3. Leukemia, 5, 813-814.
32. Traganos, F., Ardelt, B., Halko, N., Bruno, S. & Darzynkiewicz, Z. (1992) Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells. Cancer Research, 52, 6200-6208.
33. Trevillyan, J.M., Lu, Y., Alturu, D., Phillips, C.A. & Bjorndahl, J.M. (1990) Differential inhibition of T cell receptor signal transduction and early activation events by a selective inhibitor of protein tyrosine kinase. Journal of Immunology, 145, 3223-3250.
34. Udomsakdi, C. Lansdorp, P.M., Hogge, D.E., Reid, D.S., Eaves, A.C. & Eaves, C.J. (1992) Characterization of primitive hematopoietic cells in normal human peripheral blood. Blood, 80, 2513-2521.